首页 >
法规速递
-
Document: Explanatory note on the withdrawal of the interim guidance on enhanced safety surveillance for seasonal influenza vaccines in the EU-2025/12/4
2025-12-05查看详情 > -
国家药监局药审中心关于发布eCTD V3.2.2相关技术文件的通告（2026年第4号）-2026/1/15
2026-01-16查看详情 > -
国家药监局关于批准注册292个医疗器械产品的公告（2026年1月）（2026年第20号）-2026/2/25
2026-02-26查看详情 > -
Page: Availability of medicines before and during crises-2026/3/24
2026-03-25查看详情 > -
Document: List of medicinal products under additional monitoring-2026/4/29
2026-04-30查看详情 > -
Document: Change management activities delivery plan - HMA-EMA joint Big Data Steering Group-2026/6/11
2026-06-12查看详情 > -
《已上市化学药品药学变更研究技术指导原则（试行）》溶出曲线研究的问答-2022/11/8
2022-11-14查看详情 > -
Scientific guideline: Questions and answers on data requirements when replacing hydrofluorocarbons as propellants in oral pressurised metered dose inhalers-2023/4/5
2023-04-06查看详情 > -
国家药监局 国家卫生健康委关于加强依托咪酯和莫达非尼药品管理的通知-2023/10/07
2023-10-08查看详情 > -
Document: New Organisation First User EU QPPV/RP or Change of EU QPPV/RP-2025/1/7
2025-01-08查看详情 >
